Concepedia

G. Lopes

GL

Statistics

Publications

13

Citations

376

H-Index

11

Active since

2009

Affiliations

Sylvester Comprehensive Cancer Center(Current)

University of Miami

Instituto do Câncer do Estado de São Paulo

Guangdong Academy of Medical Sciences

Chinese University of Hong Kong

G. Lopes is an author at Sylvester Comprehensive Cancer Center specializing in medicine, oncology, and molecular oncology.

Publications per year

2009–2023

13

Publications

13

Association between tissue TMB (tTMB) and clinical outcomes with pembrolizumab monotherapy (pembro) in PD-L1-positive advanced NSCLC in the KEYNOTE-010 and -042 trials

Roy S. Herbst, G. Lopes, D.M. Kowalski et al. · Annals of Oncology · 2019 · 100 citations

Medicine, Clinical Sciences, Oncology +15

Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC

Tony Mok, G. Lopes, Byoung Chul Cho et al. · Annals of Oncology · 2023 · 71 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke

Grant Mair, Rüdiger von Kummer, Zoë Morris et al. · Neurology · 2015 · 41 citations · Full text

Medicine, Neurology, Radiology +17

1913O Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC)

Mimi I. Hu, Vivek Subbiah, Lori J. Wirth et al. · Annals of Oncology · 2020 · 36 citations

Medicine, Oncology, Pharmacotherapy +14

FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC

Byoung Chul Cho, Yi‐Long Wu, G. Lopes et al. · Journal of Thoracic Oncology · 2021 · 28 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 13